Stay updated on Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial

Sign up to get notified when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T01:42:56.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for the comparison of aflibercept, bevacizumab, and ranibizumab is now available, with details on the completed trial and its results-related publications. It also includes participant criteria, study locations, investigators, and record dates.
    Difference
    90%
    Check dated 2026-11-10T23:18:59.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.2 to v3.8.0 while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:07:30.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:24:03.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:28:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A 403 error page is displayed, replacing the full study record content with an access-denied screen. This blocks access to essential trial details and related sections.
    Difference
    18%
    Check dated 2026-09-22T23:31:12.000Z thumbnail image

Stay in the know with updates to Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.